Showing results (71-80 of 731) with videos related to
Sort By:
Pageof 74
Nature Reviews. Clinical Oncology|January 4, 2018
Determinants and clinical implications of chromosomal instability in cancerLaurent Sansregret, Bart Vanhaesebroeck, Charles SwantonCurrent Cancer Drug Targets|August 20, 2010
Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapiesSarah Barton, Naureen Starling, Charles SwantonMolecular Oncology|April 18, 2026
Molecular cancer prevention: Intercepting diseaseCharlotte Grieco, Tej Pandya, Charles SwantonCancer Letters|November 13, 2012
Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challengesStuart Horswell, Nicholas Matthews, Charles SwantonTrends in Molecular Medicine|May 28, 2026
Advanced imaging of immune cells for human kidney diseaseCandice Roufosse, Omar Bouricha, Alana Burrell, et al.Journal for Immunotherapy of Cancer|April 5, 2024
Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitisCathrin L C Gudd, Eoin Mitchell, Stephen R Atkinson, et al.Research Square|December 18, 2023
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinomaRichard Houlston, Richard Culliford, Sam Lawrence, et al.Nature Reviews. Clinical Oncology|July 4, 2018
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detectionChristopher Abbosh, Nicolai J Birkbak, Charles SwantonNature Reviews. Clinical Oncology|September 21, 2022
Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challengesImran Noorani, Paul S Mischel, Charles SwantonCancer Discovery|March 2, 2026
Transcriptomic Subtypes Are Associated with Clinical Outcomes for Patients with Lung Adenocarcinoma Who Have Never SmokedAlexander A Azizi, Tej Pandya, Charles SwantonPageof 74